TA
DMTX

Teachers Advisors’s Dimension Therapeutics, Inc DMTX Stock Holding History

Teachers Advisors’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-24,886
Closed -$44K – 3274
2017
Q1 		$44K Buy
24,886
+5,682
+30% +$15.1K ﹤0.01% 3034
2016
Q4 		$84K Hold
19,204
– – ﹤0.01% 3030
2016
Q3 		$153K Hold
19,204
– – ﹤0.01% 2945
2016
Q2 		$115K Buy
19,204
+13,283
+224% +$101K ﹤0.01% 3030
2016
Q1 		$46K Hold
5,921
– – ﹤0.01% 3008
2015
Q4 		$67K Buy
+5,921
New +$74.9K ﹤0.01% 3052

Other funds holding DMTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Teachers Advisors's DMTX Position: Q2 2017 in Review

Teachers Advisors sold out of Dimension Therapeutics, Inc (DMTX) in Q2 2017, closing a stake of 24,886 shares — an estimated $44K sold.

Teachers Advisors first reported a position in DMTX in Q4 2015 and held it in 6 quarters. The position peaked at $153K in Q3 2016. 35 funds tracked by Wall St. Rank hold DMTX as of Q2 2017.

  • Teachers Advisors reported no remaining Dimension Therapeutics, Inc position as of Q2 2017 after selling out during the quarter.
  • Teachers Advisors sold 24,886 Dimension Therapeutics, Inc shares in Q2 2017, an estimated $44K.
  • Teachers Advisors first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 6 quarters.
  • Teachers Advisors's Dimension Therapeutics, Inc position peaked at $153K in Q3 2016.
  • 35 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q2 2017.

Based on Teachers Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.